Ping An Biomedical Co., Ltd. announced on August 5, 2026, that its board resolved not to reappoint WWC, P.C. as its independent registered public accounting firm, effective immediately. The company has engaged Edston Global PAC as its new auditor, effective August 6, 2026. There were no disagreements with the former auditor regarding accounting principles or financial disclosures during their tenure since 2020. This change in auditors is a material event for investors assessing governance and audit quality. The company operates in the biomedical industry.

Ping An Biomedical Co., Ltd. signed a strategic cooperation agreement with Yuan Sheng Mei Yan Health Services (Hainan) Co., Ltd. to expand product channels and market outreach. The partnership aims to achieve cumulative sales of RMB 500 million within three years by leveraging Yuan Sheng Mei Yan's health management and wellness services network. Ping An Biomedical operates in the biotechnology and healthcare products industry.

Ping An Biomedical Co., Ltd., through its wholly owned subsidiary, Meridian Industries Limited, purchased certain trademarks and associated intellectual property rights for a total consideration of USD 2,500,000. The transaction, which was completed on July 10, 2026, involved the acquisition of intellectual property from Multi Ridge (Asia) Limited. Ping An Biomedical Co., Ltd. operates in the biomedical/healthcare sector.